First MERS-CoV In U.S. Diagnosed With FDA Emergency-Authorized Test Kit
This article was originally published in The Gray Sheet
Executive Summary
The first documented Middle East respiratory syndrome coronavirus (MERS-CoV) case has appeared in the U.S., the Centers for Disease Control and Prevention confirmed May 2, and the individual was diagnosed with an MERS testing kit developed by CDC and approved for emergency use by FDA last June.
You may also be interested in...
Regulatory News In Brief
FDA announces new, consumer-friendly MedWatch form. Agency issues final guidance on injector devices used with drugs or biologics. More regulatory news.
FDA Puts Strengthened Emergency Authority To Use For Diagnostics
The agency’s diagnostic office is putting to the test new authority to grant emergency use authorization for a product before an emergency is officially declared, with an upcoming coronavirus test and a recently authorized flu test.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.